A Review on Antibiotic Drug Resistance in Escherichia Coli
Archana Singh Sikarwar1, Denishvaran Jaya Gopal2
1Dr Archana Singh Sikarwar, Human Biology Department, International Medical University, Kuala Lumpur, Malaysia.
2Denishvaran Jaya Gopal, Biomedical Science Program, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, Malaysia.
Manuscript received on 15 January 2015 | Revised Manuscript received on 21 January 2015 | Manuscript Published on 30 January 2015 | PP: 13-17 | Volume-4 Issue-8, January 2015 | Retrieval Number: G1885124714/15©BEIESP
Open Access | Editorial and Publishing Policies | Cite | Mendeley | Indexing and Abstracting
© The Authors. Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP). This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Abstract: Antibiotic drug resistance to Escherichia coli is an emerging issue for healthcare which causes public health problems and outbreak worldwide. Antibiotic resistant of E.coli can cause community and hospital acquired infections. Uses of broad-spectrum antibiotics, inadequate aseptic techniques and improper infection control measures had worsen the emergence of antibiotic resistance of E.coli. Emergence of antibiotic resistant E.coli is a major challenge to healthcare provider to create newer, better and more efficient antibiotics. Infection control measures should be taken by healthcare provider to control emergence and spread of antibiotic resistant E.coli. Further researches are needed to evaluate the available antibiotic drugs, agent and identify new drugs that can solve the issue of antibiotic resistant emergence.
Keywords: Antibiotic drug resistance, Escherichia coli, infections
Scope of the Article: Biomedical Computing